Modulating factors of radical intensity and cytotoxic activity of ascorbate (Review)

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3513-3520

  Sakagami, Hiroshi ^a   Satoh, Kazue ^b  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Ascorbate radical; ESR; Physiological role

Indexed keywords

ASCORBIC ACID; GALLIC ACID; METAL; METAL CHELATE; METHIONINE; PHENOTHIAZINE DERIVATIVE; PLASMA PROTEIN; POLYPHENOL; POLYSACCHARIDE; RADICAL;

APOPTOSIS; CALCIUM METABOLISM; CELL DEATH; CELL NUCLEUS; CELL SIZE; CYTOTOXICITY; DNA CLEAVAGE; ETIOLOGY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MYELOID LEUKEMIA; OXIDATION; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; PH; PRIORITY JOURNAL; REVIEW; TEMPERATURE SENSITIVITY;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; ASCORBIC ACID; BENZYLIDENE COMPOUNDS; CALCIUM; CELL DEATH; CHELATING AGENTS; FREE RADICALS; HL-60 CELLS; HUMANS; METHIONINE; OXIDATION-REDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030781092     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Sakagami H, Sakagami T, Takeda M, Iwaki K and Takeda K: Determination of sodium 5,6-benzylidene-L-ascorbate and related compounds by high-performance liquid chromatography. J Chromatogr 653: 37-43, 1993.
2. Sakagami H, Asano K, Fukuchi K, Gomi K, Ota H, Kazama K, Tanuma S and Kochi M: Induction of tumor degeneration by sodium benzylideneascorbate. Anticancer Res 11: 1533-1538, 1991.
3. Sakagami H, Takeda M, Utsumi A, Fujinaga S, Tsunoda A, Yasuda N, Shibusawa M, Koike T, Ota H, Kazama K, Shiokawa D, Tanuma S and Kochi M: Effect of sodium benzylideneascorbate on chemically-induced tumors in rats. Anticancer Res 13: 65-72, 1993.
4. Tanuma S, Shiokawa D, Tanimoto Y, Ikekita M, Sakagami H, Takeda M, Fukuda S and Kochi M: Benzylideneascorbate induces apoptosis in L929 tumor cells. Biochem Biophys Res Commun 194: 29-35, 1993.
5. Sakagami H, Sakagami T, Yamamura M, Takahashi H, Shibuya I and Takeda M: Stability of sodium 5,6-benzylidene-L-ascorbate. Anticancer Res 75: 1269-1274, 1995.
6. Kuribayashi N, Sakagami H, Sakagami T, Niimi E, Shiokawa D, Ikekita M, Takeda M and Tanuma S: Induction of DNA fragmentation in human myelogenous leukemic cell lines by sodium 5,6-benzylidene-L-ascorbate and its related compounds. Anticancer Res 14: 969-976, 1994.
7. Fujinaga S, Sakagami H, Kuribayashi N, Takahashi H, Amano Y, Sakagami T and Takeda M: Possible role of hydrogen peroxide in apoptosis induction by ascorbic acid in human myelogenous leukemic cell lines. Showa Univ J Med Sci 6: 135-144, 1994.
8. Sakagami H, Kuribayashi N, Iida M, Hagiwara T, Takahashi H, Yoshida H, Shiota F, Ohata H, Momose K and Takeda M: The requirement for and mobilization of calcium during induction by sodium ascorbate and by hydrogen peroxide of cell death. Life Science 58: 1131-1138, 1996.
9. Yanagisawa-Shiota F, Sakagami H, Kuribayashi N, Iida M, Sakagami T and Takeda M: Endonuclease activity and induction of DNA fragmentation in human myelogenous leukemic cell lines. Anticancer Res 15: 259-266, 1995.
10. Noda H, Sakagami H, Kokubu F, Kurokawa M, Tokunaga H, Takeda M and Adachi M: Induction of apoptosis in human eosinophilic leukemic cell line (EOL-1). Int Arch Allergy Immunol, in press, 1997.
11. Kojima T, Sakagami H, Takeda M, Takahashi H and Fujita R: Induction of cytotoxicity and DNA fragmentation in gastrointestinal tumor cell lines by chemotherapeutic agents. Recent Advances in Gastroenterological Carcinogenesis I. (eds. by E. Tahara, K. Sugimachi and T. Oohara), pp 1131-1138, 1996.
12. Iida M, Matsumoto K, Sakagami H and Takeda M: Effect of glutathione-modulating compounds on hydrogen peroxide-induced cytotoxicity in human glioblastoma and glioma cell lines, submitted for publication.
13. Kurokawa M, Sakagami H, Kokubu F, Noda H, Adachi M and Takeda M: Induction of apoptotic cell death by direct current treatment in human leukemic cell lines. J Cancer Research Clinical Oncology, in press, 1997.
14. Kuribayashi N, Sakagami H, Iida M and Takeda M: Chromatin structure and endonuclease sensitivity in human leukemic cell lines. Anticancer Res 16: 1225-1230, 1996.
15. 2+ mobilization during cell death induction by sodium 5,6-benzylidene-L-ascorbate. Anticancer Res 16: 2629-2634, 1996.
16. Tanuma S and Shiokawa D: Multiple forms of nuclear deoxyribonuclease in rat thymocytes. Biochem Biophys Res Commun 203: 789-797, 1994.
17. Nikonova LS, Beletsky IP and Umansky SR: Properties of some nuclear nucleases of rat thymocytes and their changes in radiation-induced apoptosis. Eur J Biochem 215: 893-901, 1993.
18. Gaido ML and Cidlowski JA: Identification, purification, and characterization of a calcium-dependent endonuclease (NUC18) from apoptotic rat thymocytes. J Biol Chem 266: 18580-18585, 1991.
19. 2+-dependent endonuclease from human spleen: Purification, properties, and role in apoptosis. Biochemistry 32: 9129-9136, 1993.
20. Sakagami H and Satoh K: Prooxidant action of two antioxidants: ascorbic acid and gallic acid. Anticancer Res 17: 221-224, 1997.
21. Sakagami H, Satoh K, Kadofuku T and Takeda M: Methionine oxidation and apoptosis induction by ascorbate, gallate and hydrogen peroxide. Anticancer Res 17: in press, 1997.
22. Sakagami H, Satoh K, Fukuchi K, Kadofuku T, Gomi K, Nakamura K, Kuribayashi N, Sunaga S, Hirota N, Iida M, Makino Y, Kojima T, Shimura H and Takeda M: Effect of methionine depletion on growth and apoptosis in various tumor cell lines. Anticancer Res 17: in press, 1997.
23. Roch AM, Quash G, Michal Y, Chantepie J, Chantegrel B, Deshayes C, Doutheau A and Marvel J: Altered methional homeostasis is associated with decreased apoptosis in BAF3 bcl2 murine lymphoid cells. Biochem J 313: 973-981, 1996
24. Sakagami H, Satoh K, Ohata H, Takahashi H, Yoshida H, Iida M, Kuribayashi N, Sakagami T, Momose K and Takeda M: Relationship between ascorbyl radical intensity and apoptosis-inducing activity. Anticancer Res 16: 2635-2644, 1996.
25. Iyanagi T, Yamazaki I and Anan KF: One-electron oxidation-reduction properties of ascorbic acid. Biochim Biophys Act 806: 255-261, 1985.
26. Leung PY, Miyashita K, Young M and Tsao CS: Cytotoxic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines. Anticancer Res 13: 475-480, 1993.
27. Windler BS, Orselli SM and Rex TS: The redox couple between glutathione and ascorbic acid: A chemical and physiological perspective. Free Radic Biol Med 17: 333-349, 1994.
28. Satoh K, Sakagami H and Nakamura K: Enhancement of radical intensity and cytotoxic activity of ascorbate by hyperthermia. Anticancer Res 16: 2987-2992, 1996.
29. Washko PW, Wang Y and Levine M: Ascorbic acid recycling in human neutrophils. J Biol Chem 268: 15531-15535, 1993.
30. Bergstein P, Amitai G, Kehrl J, Dhariwal KR, Klein HG and Levine M: Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes. J Biol Chem 265: 2584-2587, 1990.
31. Sakagami H and Satoh K: The interaction between two antioxidants, sodium ascorbate and gallic acid: radical intensity and apoptosis induction. Anticancer Res 16: 1231-1234, 1996.
32. Satoh K and Sakagami H: Effect of metal ions on radical intensity and cytotoxic activity of ascorbate. Anticancer Res 17: 1125-1130 1997.
33. Satoh K and Sakagami H: Effect of copper and iron ions on cytotoxicity induced hy ascorbate, gallate and caffeate. Anticancer Res 17: in press, 1997.
34. Satoh K, Kadofuku T and Sakagami H: Copper, hut not iron, enhances apoptosis-inducing activity of antioxidants. Anticancer Res 17: in press, 1997.
35. Sakagami H, Satoh K, Fukuchi K, Gomi K and Takeda M: Effect of an iron-chelator on ascorhate-induced cytotoxicity. Free Radic Biol Med 23: in press, 1997.
36. Darley-Usmar VM, Hersey A and Garland LG: A method tor the comparative assessment of antioxidants as peroxyl radical scavenger. Biochem Pharmacol 38: 1465-1469, 1989.
37. Brodie C, Siriwardana G, Lucas J, Schleicher R, Terada N, Szepesi A, Gelfand E and Seligman P: Neuroblastoma sensitivity to growth inhibition by deferrioxamine: Evidence for a block in G1 phase of the cell cycle. Cancer Res 53: 3968-3975, 1993.
38. Bomford A, Issac J, Roberts S, Edwards A, Young S and Williams R: The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukaemic cells. Biochem J 236: 243-249, 1986.
39. Satoh K Ida Y, Kochi M, Tajima M, Kashimata M and Sakagami H: Effect of metals and antagonists on the radical intensity and cytotoxicity of ascorbates. Anticancer Res 17: in press, 1997.
40. Satoh K and Sakagami H: Effect of cysteine, N-acetyl-L-cysteine and glutathione on cytotoxic activity of antioxidants. Anticancer Res 17: in press, 1997.
41. Sakagami H, Satoh K, Makino Y, Kojima T and Takeda M: Effect of α-tocopherol on cytotoxicity induced by UV irradiation and antioxidants. Anticancer Res 17: in press, 1997.
42. Satoh K, Kadofuku T and Sakagami H: Effect of Trolox, a synthetic analog of α-tocopherol, on cytotoxicity induced by UV irradiation and antioxidants. Anticancer Res, 17: in press 1997.
43. Sakagami H and Satoh K: Effect of ascorbate oxidase on radical intensity and cytotoxic activity of ascorbate. Anticancer Res 17: in press, 1997.
44. Sakagami H, Satoh K, Sugaya K, Iida M, Hirota N, Matsumoto K, Kimura S, Gomi K, Taguchi S, Kato S and Takeda M: Effect of the type of serum in the medium on sodium ascorbate-induced cytotoxicity. Anticancer Res 16: 1937-1942, 1996.
45. Sakagami H, Satoh K, Taguchi S and Takeda M: Inhibition of cytotoxic activity of ascorbate by human cancer patient sera. Anticancer Res 17: 425-428, 1997.
46. Satoh K and Sakagami H: Ascorbyl radical scavenging activity of polyphenols. Anticancer Res 16: 2885-2890, 1996.
47. Satoh K, Sakagami H and Nakamura K: Enhancement of radical intensity and cytotoxic activity of ascorbate by PSK and lignins. Anticancer Res 16: 2981-2986, 1996.
48. Sakagami H, Satoh K, Aiuchi T, Nakaya K and Takeda M: Stimulation of ascorbate-induced hypoxia by lignin. Anticancer Res 17: in press, 1997.
49. Sakagami H, Kawazoe Y, Komatsu N, Simpson A, Nonoyama M, Konno K, Yoshida T, Kuroiwa Y and Tanuma S: Antitumor, antiviral and immunopotentiating activities of pine cone extracts: Potential medicinal efficacy of natural and synthetic lignin-related materials (Review). Anticancer Res 11: 881-889, 1991.
50. Sakagami H and Satoh K: Stimulation of two step degradation of sodium ascorbate by lignins. Anticancer Res 16: 2849-2852, 1996.
51. Sakagami H, Unten S, Hanaoka A, Ohsawa N, Fujimaki M, Komatsu N, Ichikawa S, Hata N, Kondo H and Konno K: Chemical modification potentiates paramylon induction of antimicrobial activity. In Vivo 3: 243-248, 1989.
52. Sakagami H, Kikuchi K, Takeda M, Sato T, Ichikawa S, Fujimaki M, Wada C and Komatsu N: Macrophage stimulation activity of antimicrobial N,N,dimethylaminoethyl paramylon. In Vivo 5: 101-106, 1991.
53. Sakagami H, Aoki T, Simpson A and Tanuma S: Induction of immunopotentiation activity by a protein-bound polysaccharide. PSK (Review). Anticancer Res 11: 993-1000, 1991.
54. Sakagami H, Kuribayashi N, Iida M, Sakagami T, Takeda M, Fukuchi K, Gomi K, Ohata H, Momose K, Kawazoe Y, Hatano T, Yoshida T and Okuda T: Induction of DNA fragmentation by tannin- and lignin-related substances. Anticancer Res 15: 2121-2128, 1995.
55. Inoue M, Suzuki R, Koide T, Sakaguchi N, Ogihara Y and Yabu Y: Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochem Biophys Res Commun 204: 898-904, 1994.
56. Sakagami H, Satoh K, Hatano T, Yoshida T and Okuda T: Possible role of radical intensity and oxidation potential for gallic acid-induced apoptosis. Anticancer Res 17: 377-380, 1947.
57. Satoh K, Sakagami H and Motohashi N: Radical modulation activity of benzo[a]phenothiazine. Anticancer Res 17: in press, 1997.
58. Satoh K, Sakagami H, Kurihara T and Motohashi N: Radical intensity and differentiation-inducing activity of benzo[a]phenothiazines and phenothiazines. Anticancer Res 17: in press, 1997.
59. Takeda M, Takayama S, Takeda K and Sakagami H: Smoking and expression of cytokine (in Japanese). Smoking Res Found Ann Res Report. p319-323, 1994.
60. Sakagami H, Takayama S, Takeda M, Fukuchi K, Gomi K, Ohata H and Momose K: Smoking and expression of cytokine. Analysis of DNA fragmentation induced by nicotine in human myelogenous leukemic cell lines (in Japanese). Smoking Res Found Ann Res Report p481-485, 1995.
61. Takeda M, Takayama S, Sakagami H and Iwamoto S: Smoking and expression of cytokine. Calcium mobilization during nicotine-induced cell death in human glioma and glioblastoma cell lines, (in Japanese). Smoking Res Found Ann Res Report p521-526, 1996.
62. Satoh K, Sakagami H, Kadofuku T, Kurihara T and Motohashi N: Radical intensity and carcinogenic activity of benz[c]acridines. Anticancer Res 17: in press, 1997
63. Kochi M, Takeuchi S, Mizutani T, Mochizuki K, Matsumoto Y and Saito Y: Antitumor activity of benzaldehyde. Cancer Treat Rep 64: 21-23, 1980.
64. Kochi M, Isono N, Niwayama M and Shirakabe K: Antitumor activity of a benzaldehyde derivative. Cancer Treat Rep 69: 533-537, 1985.
65. Kochi M, Ueda S and Hagiwara T: Antitumor activity of sodium benzylideneascorbate. In: Bresciani F, King RJB, Lippman ME and Raynaud JP (eds), Progress in Cancer Research and Therapy Vol 35: Hormon and Cancer 3, Raven Press, Ltd. New York, 1988, pp. 338-343.
66. Tatsumura T, Tsujimoto M, Koyama S, Furuno T, Komori Y, Sato H, Yamamoto K, Kitagawa M and Kagamimori S: 4,6-O-Benzylidene-D-glucopyranose (BG) in the treatment of solid malignant tumours, and extended phase I study. Br J Cancer 62: 436-439, 1990.
67. Cameron E and Pauling L: Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 73: 3685-3869, 1976.
68. Cameron E and Pauling L: Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 75: 4538-4542, 1976.
69. Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ and Ames MM: High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. New Eng J Med 312: 137-141, 1985.
70. Wittes RE: Vitamin C and cancer. New Eng J Med 312: 178-179, 1985.
71. Satoh K, Ao Y, Asano K and Sakagami H: Rapid determination of ascorbate by ESR spectroscopy. Anticancer Res 17: in press, 1997